SAM
GILD icon

Strategy Asset Managers’s Gilead Sciences GILD Stock Holding History

Strategy Asset Managers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,244
Closed -$766K – 273
2025
Q4 		$766K Buy
6,244
+96
+2% +$11.7K 0.13% 116
2025
Q3 		$682K Buy
+6,148
New +$699K 0.12% 128
2024
Q3 		– Sell
-9,451
Closed -$728K – 279
2024
Q2 		$728K Buy
+9,451
New +$631K 0.16% 102
2024
Q1 		– Sell
-5,608
Closed -$454K – 239
2023
Q4 		$454K Sell
5,608
-999
-15% -$77.7K 0.11% 140
2023
Q3 		$495K Sell
6,607
-2,844
-30% -$219K 0.13% 126
2023
Q2 		$728K Buy
9,451
+274
+3% +$21.9K 0.16% 102
2023
Q1 		$761K Buy
+9,177
New +$760K 0.19% 91
2014
Q3 		– Sell
-58,963
Closed -$4.89M – 137
2014
Q2 		$4.89M Sell
58,963
-11,053
-16% -$860K 1.04% 28
2014
Q1 		$4.96M Sell
70,016
-20,394
-23% -$1.6M 1.07% 29
2013
Q4 		$6.79M Sell
90,410
-1,439
-2% -$100K 1.49% 27
2013
Q3 		$5.78M Sell
91,849
-520
-0.6% -$31.1K 1.36% 28
2013
Q2 		$4.74M Buy
+92,369
New +$4.81M 1.13% 28

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Strategy Asset Managers's GILD Position: Q1 2026 in Review

Strategy Asset Managers sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 6,244 shares — an estimated $766K sold.

Strategy Asset Managers first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $6.79M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Strategy Asset Managers reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Strategy Asset Managers sold 6,244 Gilead Sciences shares in Q1 2026, an estimated $766K.
  • Strategy Asset Managers first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Strategy Asset Managers's Gilead Sciences position peaked at $6.79M in Q4 2013.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.